Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 237
Medicare Laboratory Payment Policy: Now and in the Future APPENDIX F Committee Biographies Lauren LeRoy, Ph.D., is president and chief executive officer of Grantmakers In Health, a nonprofit educational organization serving health foundations. Previously, she was executive director of the Medicare Payment Advisory Commission (MedPAC), a nonpartisan congressional advisory body. Prior to MedPAC, she served as executive director of the Physician Payment Review Commission (PPRC). She came to PPRC from the Commonwealth Fund Commission on Elderly People Living Alone, where she served as associate director. Dr. LeRoy spent more than a decade at the Institute for Health Policy Studies, University of California, San Francisco, where she was assistant director and directed the Institute’s Washington office. She began her career as a health policy analyst in the Department of Health, Education, and Welfare. Dr. LeRoy’s work has focused on Medicare reform, the health work force, health care for the elderly, and health philanthropy. She received a doctorate in social policy planning from the University of California, Berkeley. She is a member of the National Academy of Social Insurance and a fellow of the Academy for Health Services Research and Health Policy. Howard Bailit, D.M.D., Ph.D., is professor and director of the Health Policy and Primary Care Research Center at the University of Connecticut School of Medicine and a research associate at the Sloan Managed Care Research Center, Harvard University. He is responsible for developing health services and policy research at the University of Connecticut. Prior to these positions, he was a senior vice president for medical policy and programs at Aetna Health Plans (1986–1995). He has also held academic positions at Columbia University, School of Public Health (1982–1986), where he chaired the Department of
OCR for page 238
Medicare Laboratory Payment Policy: Now and in the Future Health Administration and Policy, and the University of Connecticut Health Center (1967–1982), where he served as head of Behavioral Sciences and Community Health. He received his dental degree from Tufts and his Ph.D. from Harvard. He has published widely on health policy and managed care and serves on many national committees and editorial boards. He has been a member of the Institute of Medicine (IOM) since 1984. Christopher Bladen, M.Sc., has more than five years’ experience as an independent consultant. His activities have chiefly been devoted to providing advice to donor agencies, developing countries, and newly independent nations of the former Soviet Bloc regarding health care and health care financing reform, and conducting baseline studies of health sector costs. For 20 years, Mr. Bladen served in the health policy component of the Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services (DHHS). During this period he directed the Divisions of Science and Health Policy, Health Care Financing, and Health Economics. Prior to his retirement, he served as the deputy to the deputy assistant secretary for health policy for five years. He received his B.A. (political science) from Williams College, Williamstown, Massachusetts, and his M.Sc. (economics) from the London School of Economics and Political Science, London, UK; he passed Ph.D. comprehensive examinations (political science) from the Maxwell School, Syracuse University, Syracuse, N.Y. Mr. Bladen has received a postdoctoral fellowship from the American Society for Public Administration. He has also received various departmental and secretarial awards from the U.S. Departments of Commerce and Health and Human Services. William Hsiao, Ph.D., is the K.T.Li Professor of Economics and director of the Program in Health Care Financing at the Harvard School of Public Health. His current research focuses on developing a theory of health system economics. His research also concentrates on payment for hospital and physician services, social and private insurance, and competition in managed care markets. Dr. Hsiao received his Ph.D. in economics from Harvard University, and he is also a qualified actuary. He was named the Man of the Year in Medicine for his work developing a rational fee schedule for physician services, the resource-based relative value scale (RBRVS), which has been adopted by the United States, Australia, Canada, and France. He was awarded honorary professorships by several leading Chinese universities. He is a member of the National Academy of Sciences and serves on the Board of Directors for both the National Academy of Social Insurance and the Society of Actuaries. He has advised the U.S. Congress, the White House, the World Bank, the International Monetary Fund, the World Health Organization, and many nations. William B.Kerr, M.H.A., is currently the Senior Vice President of The Hunter Group. He served in a variety of administrative positions at the University of California, San Francisco Medical Center over the past 30 years, including 19
OCR for page 239
Medicare Laboratory Payment Policy: Now and in the Future years as medical center director. Mr. Kerr earned a B.S. in social science from Loyola University in 1964 and a graduate degree in hospital administration from the University of Minnesota in 1969. He was the recipient of the California Association of Hospitals and Health Systems Certificate of Distinction, the Association of American Medical Colleges Distinguished Service Award, and the University of California San Francisco Medal. Mr. Kerr served as a member of the Board of Governors of the National Institutes of Health Clinical Center and is currently a member of the IOM and the Commonwealth Fund Task Force on Academic Health Centers. J.Stephen Kroger, M.D., is Chief Executive Officer of COLA (formerly the Commission on Office Laboratory Accreditation), an organization that accredits more than 7,200 physician office laboratories in the United States. His past experience includes 25 years of direct patient care as a practicing internist, development of workable standards for office laboratories, implementation of the Clinical Laboratory Improvement Amendments regulations, and work in the general areas of quality improvement in the laboratory and medical practice settings. He has served as a consultant to the Centers for Disease Control and Prevention, and served as a member of the DHHS Clinical Laboratory Improvement Advisory Committee from 1992 to 1996. He has testified before various House and Senate subcommittees on laboratory issues. He is a fellow of the American College of Physicians and a member of the American Medical Association and the American Society of Association Executives. Dr. Kroger received his doctorate in medicine from the University of Cincinnati in 1965 and board certification in internal medicine in 1972. John Matsen, M.D., is a Professor Emeritus of pathology and pediatrics at the University of Utah. He served as chair of the Department of Pathology from 1981 to 1993. He was the president and chief executive officer of Associated Regional and University Pathologists, Inc. from 1984 to 1993 and board chair from 1993 to 1999. Dr. Matsen served as senior vice president for health sciences at the University of Utah from January 1993 to December 1998. He has served as president of the Academy of Clinical Laboratory Physicians and Scientists and as president of the Association of Pathology Chairs. Dr. Matsen’s M.D. degree was awarded by the University of California at Los Angeles. He is the recipient of many prestigious awards including the Becton-Dickinson Award from the American Society for Microbiology. Dr. Matsen currently serves on the Board of Directors of ASM-Resources, Inc., a for-profit, subsidiary corporation of the American Society for Microbiology. Stephen T.Mennemeyer, Ph.D., is a professor in the Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham. He teaches and conducts research on health economics and the cost-effectiveness of health care interventions. Previously he was senior econo-
OCR for page 240
Medicare Laboratory Payment Policy: Now and in the Future mist at Abt Associates Inc. in Cambridge, Massachusetts. There he conducted studies of the administrative costs of the Medicare program, competitive bidding systems, and patient outcomes following clinical laboratory tests. Dr. Mennemeyer holds a Ph.D. in economics from the State University of New York at Buffalo. He is a member of the American Economics Association, American Public Health Association, International Health Economics Association, Society for Medical Decision Making, and Southern Economics Association. David L.Smalley, Ph.D., is a professor of pathology at the University of Tennessee, Health Sciences Center, Memphis, Tennessee. He has been a faculty member with the University since 1980 and has been actively involved in teaching and research at the medical school, allied health programs, and residency programs. He also serves as technical director of the Memphis Pathology Laboratory (MPL), L.L.C. in Memphis. Dr. Smalley has been a consultant to MPL since 1986, serving as the technical director for immunology and clinical chemistry. Dr. Smalley holds a bachelor’s degree in medical technology. He holds a master’s degree and Ph.D. in microbiology-immunology and is licensed by the State of Tennessee as a general medical laboratory director. He was the 1998 recipient of the Outstanding Reserve/Guard Laboratorian Award from the Society for Armed Forces Medical Laboratory Scientists. He is a member of the American Association of Bioanalysts, American Society for Microbiology, Clinical Laboratory Management Association, and American Association of Immunologists. Earl P.Steinberg, M.D., M.P.P., is a senior vice president of research and development and industry affairs for Resolution Health Strategies, Inc. and an adjunct professor of medicine and of health policy and management at Johns Hopkins University. From 1994 to February 2000, Dr. Steinberg was vice president of Covance Health Economics and Outcomes Services Inc., director of its Quality Assessment and Improvement Systems Division, and codirector of its Outcomes Studies Group. Prior to joining Covance, Dr. Steinberg was professor of medicine and of health policy and management at Johns Hopkins University, and director of the Johns Hopkins Program for Medical Technology and Practice Assessment. While at Johns Hopkins, Dr. Steinberg was the principal investigator on the federally funded Patient Outcome Research Team that evaluated the management of cataracts. Dr. Steinberg received his A.B. degree from Harvard College (summa cum laude), his M.D. from Harvard Medical School, and a master of public policy degree from the Kennedy School of Government at Harvard. His residency training in internal medicine was performed at the Massachusetts General Hospital. Dr. Steinberg has received numerous awards and is a fellow of the American College of Physicians and the Academy for Health Services Research and Health Policy. He has served for 10 years as a member of the National Blue Cross/Blue Shield Association’s Medical Advisory Panel and served for four years on the federal Physician Payment Review Commission.
OCR for page 241
Medicare Laboratory Payment Policy: Now and in the Future Bruce Steinwald, M.B.A., is an independent consultant in Washington, D.C., specializing in health economics consulting for health care delivery and financing organizations. Until the fall of 1999, Mr. Steinwald was a senior fellow at the National Health Policy Forum, George Washington University, and before that he was vice president of Covance Health Economics and Outcomes Services, Inc. where he directed the company’s Outcomes Studies Group and initiated its European practice. In the 1980s, Mr. Steinwald worked in the Office of the Secretary, Department of Health and Human Services, and was deputy director of the Prospective Payment Assessment Commission (now MedPAC). He received his B.A. degree from Johns Hopkins University and his M.B.A. in health administration from the University of Chicago, Graduate School of Business, where he also completed all requirements except the dissertation for a Ph.D. in economics. Mr. Steinwald served on the National Committee on Vital and Health Statistics from 1988 to 1996 and is currently a member of the Academy for Health Services Research and Health Policy and the Society for Health Service Administrators. Eleanor Travers, M.D., M.H.A., is a physician executive and health care system administrator, currently in public service at the U.S. Department of Veterans Affairs (VA) Headquarters in Washington, D.C, where she is the clinical manager for utilization and capacity management and the national medical advisor for cost-effectiveness. Previously, she was a chief executive officer and medical director for the nation’s largest clinical laboratory system and chief of service and professor at numerous medical school-affiliated hospitals. Dr. Travers has a wide scope of health care administrative, legislative policy, quality, and cost analysis experience and is nationally known for her textbooks, published writings, and teaching on laboratory management and cost accounting. She created the legislative pathway for and authored the VA’s Clinical Laboratory Improvement Amendments in 1993 and has testified before the Congress as an expert in quality improvement, personnel, and information technology issues. From 1984 to 1987 she served on the Methods Panel for the IOM Council on Health Care Technology. She is a graduate of Boston University (AB), the Medical College of Pennsylvania (MD), and George Washington University (MHA).
OCR for page 242
Medicare Laboratory Payment Policy: Now and in the Future This page in the original is blank.
Representative terms from entire chapter: